Kyntra Bio, Inc. - Common Stock (NQ:KYNB)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
81.1% below 52-week high
1.830
1.7852W Low
9.7052W High
1 Week
54.1% below 1-week high
1.781W Low
3.991W High
Kyntra Bio, Inc. - Common Stock (KYNB) traded between $1.78 and $9.70 over the past 52 weeks and last traded at $1.83, 81.1% below its 52-week high. Over the past week it ranged between $1.78 and $3.99.
Past 12 Months
1W
-$1.61
1M
-$3.45
3M
-$5.49
6M
-$5.11
YTD
-$7.67
1Y
-$7.67
KYNB was -80.7% over the past year, -73.6% over six months, -80.7% year to date, -46.8% in the last week.
12 Months vs Market
KYNB
DIA
SPY
QQQ
IWM
Over the past 12 months KYNB returned -80.7% versus DIA (Dow) +6.3%, SPY (S&P 500) +8.0%, QQQ (Nasdaq 100) +7.5% and IWM (Russell 2000) +13.2%.
Volume & Liquidity
1.46× 3-mo avg
Today 43,675
3-mo avg 29.9K
1W
1M
3M
6M
YTD
1Y
KYNB most recently traded 43,675 shares against a 3-month average daily volume of 29.9K. More NewsRead More
Kyntra Bio Q2 2026 Earnings Call: Complete Transcript ↗
August 13, 2026
Kyntra Bio (KYNB) Q1 2026 Earnings Transcript ↗
May 11, 2026
Kyntra Bio (KYNB) Q4 2025 Earnings Call Transcript ↗
March 16, 2026
Frequently Asked QuestionsIs Kyntra Bio, Inc. - Common Stock publicly traded?
Yes, Kyntra Bio, Inc. - Common Stock is publicly traded.
What exchange does Kyntra Bio, Inc. - Common Stock trade on?
Kyntra Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kyntra Bio, Inc. - Common Stock?
The ticker symbol for Kyntra Bio, Inc. - Common Stock is KYNB on the Nasdaq Stock Market
What is the current price of Kyntra Bio, Inc. - Common Stock?
The current price of Kyntra Bio, Inc. - Common Stock is 1.830
When was Kyntra Bio, Inc. - Common Stock last traded?
The last trade of Kyntra Bio, Inc. - Common Stock was at 11/19/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||